David Anderson is Board Member of Vibalogics since 2019 and brings over 20 years of experience in the strategic build and investment of businesses across the global life science, biotechnology, and medical device sectors. David is General Partner of Ampersand Capital Partners, having joined in 2010, and prior to Ampersand spent six years with Covington Associates, a specialty investment bank. Prior to Covington, David spent five years as a consultant for Boston Healthcare Associates. David’s current and past board membership include BioClinica, BrammerBio, Cellero, Arranta Bio, GeneWerk, Genezen, StageBio, and Vibalogics. David holds a B.Sc. from the University of Aberdeen, a Ph.D. in Immunology from the University of Sheffield and a M.B.A. from Babson College.
David Q. Anderson, Ph.D.